GlassScriptPhysician profile
Abhimanyu Uberoi
NPI 1902115520
$41,193.60
in general payments reported to CMS, 2019-2025
15 companies · $20K in 2025
The $20K reported for 2025 was more than what 93% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,209 · 2020: $737 · 2021: $918 · 2022: $4,020 · 2023: $4,097 · 2024: $8,870 · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $9,250 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,250 · Consulting Fee: $3,281.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,527.82 |
| Travel and Lodging | $9,249.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,250.00 |
| Consulting Fee | $3,281.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $13,746.70 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $13,467.54 | 2019-2025 | Amplatzer Amulet, Amplatzer Talisman, Triclip |
| Boston Scientific Corporation | $7,044.18 | 2019-2025 | Watchman Access System, Versacross Access Solution, Watchman Flx |
| Medtronic, INC. | $2,657.69 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Siemens Medical Solutions USA, INC. | $2,103.83 | 2022 | |
| Philips North America LLC | $974.03 | 2022-2025 | (Bs3) Intracardiac Und, Igt Devices Undivided, Epiq Cvx |
| W. L. Gore & Associates, INC. | $466.74 | 2019-2024 | Gore Cardioform Septal Occluder |
| Shockwave Medical, INC | $259.35 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $127.05 | 2021 | |
| Abiomed | $111.84 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $89.07 | 2019-2020 | |
| Cathworks, INC. | $85.90 | 2023 | Ffrangio |
| Cardiva Medical, INC. | $34.16 | 2025 | Savvywire |
| Recor Medical INC | $25.52 | 2024 | Paradise Renal Denervation System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abhimanyu Uberoi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.